Controversy over domestic drugmaker Medigen’s COVID-19 vaccine could have been avoided had the company published data on its phase 2 clinical trials in international journals, National Taiwan University (NTU) College of Public Health vice dean Tony Chen (陳秀熙) said yesterday.
The government on Sunday granted emergency use authorization (EUA) to the Medigen jab after an expert panel said that antibody levels in the blood of phase 2 trial participants met local standards.
However, critics said that the experts’ reasoning was not convincing because not all trial data had been publicized and that Taiwan is the only country to conditionally approve a vaccine that has not yet passed phase 3 clinical trials.
Medigen on Tuesday said it had received approval to conduct phase 3 trials on 1,000 people in Paraguay.
Chen yesterday said that the Paraguay trials’ methodology and safety precautions would be well within international standards, but whether the vaccine could provide sufficient protection, especially against highly infectious variants of SARS-CoV-2, could only be determined with additional trials.
Chen said that he believes the expert panels’ assessment on which the EUA is based, but that the company lacks sufficient credibility based on publication in scientific journals.
“Trial data of the COVID-19 vaccines that are in use worldwide — AstraZeneca, Pfizer-BioNTech, Moderna, Johnsons & Johnson and Novavax, among others — have been published in credible international journals,” Chen said, adding that this, not the transparency of the approval process in various countries, gives them credibility.
Even China last year publicized the phase 2 trial results of the Sinovac COVID-19 vaccine, he said.
The publication of trial data is a critical step that the Medigen vaccine must take, Chen said, adding that verification by the international medical community would be crucial to calm the worries of Taiwanese.
Taoyuan Mayor Cheng Wen-tsan (鄭文燦) and Tainan Mayor Huang Wei-che (黃偉哲), both of the Democratic Progressive Party, have said that they would be willing to receive the Medigen vaccine as their second shot, while New Taipei City Mayor Hou You-yi (侯友宜) of the Chinese Nationalist Party (KMT) has said that the jab’s efficacy should first be determined by the scientific community, not by politics.
Transparency is key to winning public support, Hou said, adding that public support is key to whether the Medigen jab would become widely accepted.
Additional reporting by Lai Hsiao-tung
UPGRADE: The Kang Ding-class frigate is replacing its Chaparall missiles with Tien Chien II and Hua Yang VLS, which would provide it with long-range, 360° air defense Taiwan plans to produce 1,200 to 1,376 Hai Chien II missiles (海劍二, Sea Sword II) — also known as TC-2N — to serve as the standard air defense system of the navy’s surface combatant fleet, a source said yesterday. Last week, the Hai Chien II, the naval version of the Tien Kung II missile (天劍二, Sky Sword II), completed a live-fire test in waters off the National Chungshan Institute of Science and Technology’s Jiupeng facility (九鵬) in Pingtung County’s Manjhou Township (滿州). The MIM72 Chaparral and other dated air defense missiles that currently arm Taiwanese ships have inadequate range to combat Chinese
REASONS FOR TRAVEL: An assistant professor said that proposed amendments to penalize drivers if they used drugs overseas would not deter people from traveling People who operate a motor vehicle under the influence of marijuana would have their driver’s license revoked, even if they used the substance while overseas, the Ministry of Transportation and Communications said yesterday, citing proposed amendments to the Road Traffic Management and Penalty Act (道路交通管理處罰條例). The amendments would also authorize the government to revoke the licenses of people determined to have used Category 1 or Category 2 narcotics, even if they were not operating a vehicle while under the influence of drugs, as well as ban them from taking the license test for three years, the ministry said. People aged 18 or
HEAVY WEATHER: Typhoon Jangmi is due to crash straight into the Ryukyus as airlines look to shift flights to larger aircraft or cancel flights to Okinawa entirely Taiwan’s international air carriers announced flight adjustments over the weekend as Typhoon Jangmi is forecast to hit the Ryukyu Islands today and tomorrow. The Central Weather Administration (CWA) upgraded Jangmi from a tropical storm to a typhoon at 8am yesterday, with the eye located 580km south of Naha city. It was moving north at 19kph. Today, China Airlines’ CI-120, CI-121, CI-122 and CI-123 flights between Taoyuan and Naha, Okinawa, have been canceled as well as CI-132 and CI-133 between Kaohsiung and Naha. EVA Air’s BR-112, BR-113, BR-186 and BR-185 flights between Taoyuan and Naha are also canceled. Low-cost carrier Tigerair Taiwan canceled IT-230,
Johanne Liou (劉喬安), a Taiwanese woman who shot to unwanted fame during the Sunflower movement protests in 2014, returned to Taiwan last night after being deported from the US. She is to stand trial in Taiwan for charges involving embezzlement, fraud and drug crimes. The Criminal Investigation Bureau (CIB) said it took her into custody at Taiwan Taoyuan International Airport and would first question her before transferring her to the New Taipei District Prosecutors’ Office. She was arrested upon disembarking a flight from San Francisco that landed shortly before 7pm. Liou absconded to the US in 2019 after jumping bail
RSS